Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Singh

Showing results (11-20 of 606) with videos related to

Pageof 61
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|December 1, 2007
The benefits of combined treatment with corticosteroids and long-acting beta agonistsDave Singh
British Journal of Clinical Pharmacology|November 8, 2014
New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectivesDave Singh
The Lancet. Respiratory Medicine|March 27, 2022
IL-33 in COPD: the hunt for responder subgroupsDave Singh
Respirology (Carlton, Vic.)|April 8, 2021
Pharmacological treatment of stable chronic obstructive pulmonary diseaseDave Singh
Tuberculosis and Respiratory Diseases|June 25, 2020
Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid EffectsDave Singh
American Journal of Respiratory and Critical Care Medicine|July 11, 2023
A New Treatment for Chronic Obstructive Pulmonary Disease: Ensifentrine Moves CloserDave Singh
Respirology (Carlton, Vic.)|September 27, 2019
One bronchodilator or two? Translating clinical trials into clinical practiceDave Singh
Respirology (Carlton, Vic.)|October 14, 2018
Double combination inhalers in COPD: How to get your head around this dataDave Singh
Tuberculosis and Respiratory Diseases|September 15, 2017
Small Airway Disease in Patients with Chronic Obstructive Pulmonary DiseaseDave Singh
Expert Opinion on Pharmacotherapy|July 10, 2018
Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary diseaseDave Singh
Pageof 61

Showing results (11-20 of 606) with videos related to

Sort By:
Pageof 61
International Journal of Chronic Obstructive Pulmonary Disease|December 1, 2007
The benefits of combined treatment with corticosteroids and long-acting beta agonistsDave Singh
British Journal of Clinical Pharmacology|November 8, 2014
New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectivesDave Singh
The Lancet. Respiratory Medicine|March 27, 2022
IL-33 in COPD: the hunt for responder subgroupsDave Singh
Respirology (Carlton, Vic.)|April 8, 2021
Pharmacological treatment of stable chronic obstructive pulmonary diseaseDave Singh
Tuberculosis and Respiratory Diseases|June 25, 2020
Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid EffectsDave Singh
American Journal of Respiratory and Critical Care Medicine|July 11, 2023
A New Treatment for Chronic Obstructive Pulmonary Disease: Ensifentrine Moves CloserDave Singh
Respirology (Carlton, Vic.)|September 27, 2019
One bronchodilator or two? Translating clinical trials into clinical practiceDave Singh
Respirology (Carlton, Vic.)|October 14, 2018
Double combination inhalers in COPD: How to get your head around this dataDave Singh
Tuberculosis and Respiratory Diseases|September 15, 2017
Small Airway Disease in Patients with Chronic Obstructive Pulmonary DiseaseDave Singh
Expert Opinion on Pharmacotherapy|July 10, 2018
Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary diseaseDave Singh
Pageof 61